Evaluating new rapid mpox diagnostic tests
Part of Infections clinical trials.
This study tests how well new rapid point-of-care mpox diagnostic tests work compared to standard lab tests. If you have stored mpox samples available, your samples could help validate these faster diagnostic methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your sample must be a lesion swab stored in VTM or UTM (special liquid preservation) that hasn't been heat-treated
- You have enough sample volume (at least 2,600 microliters) to run multiple tests
- Your sample was already tested and confirmed as either mpox-positive or mpox-negative
- Your sample was collected in 2020 or later
- Your sample hasn't been frozen and thawed more than 3 times
- Your sample was collected using non-expired swabs and fresh preservation liquid
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the medical and lab changes in people with suspected or likely monkeypox, and in adults who may be eligible for a monkeypox vaccine. Your participation helps researchers understand how infection and vaccination affect the body and how to improve care.
This study is testing a new way to diagnose mpox by collecting fluid from skin blisters. It may help confirm if you have mpox more quickly and accurately.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
This trial tests whether special paper strips can safely collect mpox samples from skin lesions and be mailed for testing. If it works, it could make diagnosis faster and easier for patients in remote areas.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This trial tests a new treatment for mpox (monkeypox) in people with active sores. It aims to see if the treatment helps clear the infection faster and reduce symptoms.
Hear when a new Monkey Pox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.